2013-03-18 03:48:34 - New Pharmaceuticals market report from MarketLine: "Johnson & Johnson: Product recalls in the OTC pharmaceuticals business"
Johnson & Johnson began as a manufacturer of surgical dressings in 1886. The company has embarked on a process of diversification with the business now operating as 3 divisions: Pharmaceutical, Consumer, and Medical Devices and Diagnostics. This growth from a small manufacturer to a large multinational company was achieved through global expansion, innovation, investment in R&D, and M&A activity.
Features and benefits
* MarketLine Case Studies describe topics such as innovative products, business models, and significant company acquisitions.
* Fact-based and presented in an accessible style, they explain the rationale of commercial decisions and illustrate wider market and economic trends.
A number of targeted acquisitions over the years have helped the company to diversify its business and become a key player in
the health care field. With regards to OTC pharmaceuticals, there have been a number of key purchases. These include the acquisition of McNeil Laboratories in 1959 and Pfizer Consumer Healthcare in 2006.
Johnson & Johnson has been the leading brand in the OTC pharmaceuticals market in the US for many years. The acquisition of Pfizer Consumer Healthcare in 2006 led to the company's market share growing from 9% to 14% of the market.
In recent years the company's OTC Pharmaceuticals & Nutritionals division has faced a series of problems regarding product quality. These problems have mainly surrounded the McNeil Healthcare business, which manufactures OTC medicines. As a result the company has had to recall a range of products starting with Motrin tablets in July 2009.
Full Report Details at
- www.fastmr.com/prod/546458_johnson_johnson_product_recalls_in_th ..
Your key questions answered
* How has the company grown from a small manufacturer of surgical dressings to a large multinational holding company?
* What is Johnson & Johnson's share of the US OTC pharmaceuticals market?
* How did the company recover from the 1982 Tylenol murders?
* Why have product recalls been occuring in recent years?
* How have these product recalls impacted the business?
Report Table of Contents:
JOHNSON & JOHNSON HAS GROWN TO BECOME A LARGE DIVERSIFIED BUSINESS
The company began as a manufacturer of surgical dressings
The company is now split into three divisions
Acquisition has been a key driver of growth for the company
Johnson & Johnson acquired McNeil Laboratories in 1959
In 2006 Johnson & Johnson acquired Pfizer Consumer Healthcare
In 2011 Johnson & Johnson bought Merck & Co. out of the companies' joint venture
JOHNSON & JOHNSON OTC PHARMACEUTICALS GREW RAPIDLY IN THE US
Johnson & Johnson is the leading brand in the US OTC pharmaceuticals market
JOHNSON & JOHNSON HAVE HAD TO RECALL A NUMBER OF PRODUCTS
In 1982 Tylenol was laced with cyanide
The company acted quickly to save its reputation
There have been numerous product recalls since 2009
The opening of the Fort Washington manufacturing facility was delayed until the end of 2013
PRODUCT RECALLS HAVE HAD AN IMPACT ON THE COMPANY'S REPUTATION AND SALES
Product recalls have affected the company's share of the US pharmaceuticals market
Johnson & Johnson continues to face threats to its market share position going forward
Ask the analyst
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.